Get the Stockscreener App
211.83
1.10%
2.30
After Hours:
211.83
Natera Inc stock is traded at $211.83, with a volume of 1.01M.
It is up +1.10% in the last 24 hours and down -12.31% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$209.53
Open:
$211.65
24h Volume:
1.01M
Relative Volume:
0.84
Market Cap:
$29.54B
Revenue:
$2.12B
Net Income/Loss:
$-309.19M
P/E Ratio:
-92.74
EPS:
-2.2841
Net Cash Flow:
$93.57M
1W Performance:
-1.72%
1M Performance:
-12.31%
6M Performance:
+30.38%
1Y Performance:
+35.79%
1-Day Range:
$209.02
$214.39
1-Week Range:
$207.01
$218.50
52-Week Range:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
211.83 | 29.22B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
513.68 | 193.72B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
209.52 | 147.88B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
657.38 | 51.84B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.72 | 35.19B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.44 | 32.01B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-26 | Initiated | Citigroup | Buy |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-27-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-22-25 | Resumed | Wells Fargo | Equal Weight |
| Mar-13-25 | Initiated | RBC Capital Mkts | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Assessing Natera (NTRA) Valuation After Positive SINERGY Trial Results In Head And Neck Cancer - simplywall.st
A Preview Of Natera's Earnings - Benzinga
Natera says Phase 2 SINERGY trial met primary endpoint - TipRanks
Natera Earnings: What To Look For From NTRA - Finviz
Natera (NTRA) Reports Success in SINERGY Trial for Head and Neck Cancer - GuruFocus
Chemo cut by two-thirds with ctDNA-guided care in head and neck cancer study - Stock Titan
Is Natera (NTRA) Fairly Priced After Recent Share Price Pullback? - Yahoo Finance
How Surging Signatera Oncology Volumes At Natera (NTRA) Have Changed Its Investment Story - simplywall.st
Justices Want Natera's Take On CareDx's False Ad Petition - Law360
Natera, Inc. (NTRA) Stock Analysis: High Growth Potential With 21.25% Upside - DirectorsTalk Interviews
Aug Highlights: Is Natera Inc stock forming a triangle patternJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - baoquankhu1.vn
Unveiling Natera (NTRA) Q4 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance
Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks - The Motley Fool
Vanguard Group Inc. Sells 287,620 Shares of Natera, Inc. $NTRA - MarketBeat
How does Natera Inc. compare to its peers2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - mfd.ru
Cibc World Market Inc. Sells 6,191 Shares of Natera, Inc. $NTRA - MarketBeat
Will Natera Inc. stock reach all time highs in 2025New Guidance & Daily Technical Stock Forecast Reports - mfd.ru
CtDNA Detection Market Set to Witness Massive Growth by 2033: Key Players • Roche • Biocept • Natera • Illumina - openPR.com
Natera targets ex-employee over mass file download before rival move - Life Sciences Intellectual Property Review
Natera (NTRA) to Release Earnings on Thursday - MarketBeat
Assessing Natera (NTRA) Valuation After Launch Of EDEN Preeclampsia Risk Study - simplywall.st
Natera Accuses Worker Who Went to Competitor of Stealing Secrets - Bloomberg Law News
Analysts Offer Insights on Healthcare Companies: American Well (AMWL), Centene (CNC) and Natera (NTRA) - The Globe and Mail
Natera, Inc. $NTRA Shares Sold by Eagle Health Investments LP - MarketBeat
Readystate Asset Management LP Invests $12.74 Million in Natera, Inc. $NTRA - MarketBeat
Piper Sandler reiterates Natera stock rating on Japan expansion By Investing.com - Investing.com South Africa
CareDx gets $96M jury verdict overturned in Natera patent dispute - MSN
Piper Sandler reiterates Natera stock rating on Japan expansion - Investing.com
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026 - Yahoo Finance
Zweig DiMenna Associates LLC Buys 8,400 Shares of Natera, Inc. $NTRA - MarketBeat
JPMorgan Chase & Co. Buys 1,003,129 Shares of Natera, Inc. $NTRA - MarketBeat
Natera's Signatera test to be covered under Medicare - MSN
Natera, Inc. (NTRA) Stock Analysis: Unpacking the 24.72% Potential Upside in the Diagnostics Powerhouse - DirectorsTalk Interviews
Natera, Inc. (NTRA) reports preliminary Q4 revenue - MSN
How (NTRA) Movements Inform Risk Allocation Models - Stock Traders Daily
CareDx Seeks High Court Review Of $45M False Ad Case - Law360
Prenatal Testing Co. Missed Fatal Condition, Couple Say - Law360
MSN Money - MSN
Krilogy Financial LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Allspring Growth Fund Q4 2025 Fund Performers And Detractors - Seeking Alpha
Envestnet Asset Management Inc. Purchases 17,254 Shares of Natera, Inc. $NTRA - MarketBeat
How Natera Inc. stock trades before earnings2025 Dividend Review & Real-Time Buy Signal Notifications - mfd.ru
Natera Inc (NTRA) Trading 3.93% Higher on Feb 9 - GuruFocus
When Will Natera, Inc. (NASDAQ:NTRA) Breakeven? - 富途牛牛
Earnings Miss: What are analysts price targets for Natera Inc2025 Market Overview & Pattern Based Trade Signal System - baoquankhu1.vn
Natera, Inc. $NTRA Shares Sold by Savant Capital LLC - MarketBeat
Is Natera (NTRA) Quietly Redefining Its Moat With Multi-Front Cell-Free DNA Expansion? - simplywall.st
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes - Yahoo Finance
AGF Management Ltd. Sells 6,300 Shares of Natera, Inc. $NTRA - MarketBeat
This brand-new Peninsula building sat vacant for a year. Now it's landed two big tenants - The Business Journals
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.02%
2.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):